Oxfordbiotherapeutics
The Senior Scientist will lead the discovery and development of T-cell engagers, designing and executing in vitro functional assays, flow cytometry, and primary human T-cell studies to generate decision-driving data from early discovery through IND. The role combines hands‑on experimental work with scientific leadership, cross‑functional collaboration, and communication of findings to project teams and external partners.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2004
Oxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
9% above the average for this role
Postdoctoral Research Fellow
Eli Lilly and Company
Senior Scientist I, Oncology Research
CytomX Therapeutics
Senior Research Associate*
bighatbiosciences
Associate Scientist, Oncology Research
CytomX Therapeutics
Scientist, Immunology Cell Therapy Discovery (In Vitro Focus)
AstraZeneca
Scientist II, In Vitro Pharmacology
AbbVie